少白细胞输血技术降低输血不良反应的临床效果研究  

Clinical Effect of Less Leukocyte Transfusion Technology to Reduce Adverse Transfusion Reactions

作　　者：黎云[1] 

机构地区：[1]惠州市中心血站,广东惠州516003

出　　处：《广东微量元素科学》2016年第3期31-33,共3页Trace Elements Science

摘　　要：目的对比分析少白细胞输血与常规输血在降低输血不良反应方面的差异。方法选取惠州市第一人民医院收治的患者161例,随机分为两组,其中观察组81例,选用少白细胞输血技术进行输血,对照组80例,进行常规输血治疗,观察并比较两组患者输血后不良反应情况。结果观察组不良反应例数明显低于对照组,比较差异有统计学意义(P<0.05)。结论少白细胞输血技术相较于常规输血技术可有效减少输血不良反应的发生,提高对危急患者的抢救效果,值得在临床上予以推广。ObjectiveTo compare the difference between leukocyte transfusion and conventionaltransfusion in reducing adverse aspects. Methods 161 cases of patients admitted to our hospital wererandomly divided into two groups. For 81 cases in the observation group, chose less leukocyte bloodtransfusion, for 80 cases in the control group, chose conventional blood transfusion therapy, and the twogroups were observed after transfusion reactions. Results The number of cases of adverse reactions wassignificantly lower than that of the control group, the difference was statistically significant （P 〈 0.05 ）.Conclusion Compared to the conventional technology, less leukocyte transfusion technology caneffectively reduce the incidence of adverse reactions and improve the rescue effect for critical patients; itdeserves to be used in clinical practice.

关 键 词：少白细胞输血 不良反应 输血 

分 类 号：R457.1[医药卫生—治疗学]